JP2009530316A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530316A5
JP2009530316A5 JP2009500668A JP2009500668A JP2009530316A5 JP 2009530316 A5 JP2009530316 A5 JP 2009530316A5 JP 2009500668 A JP2009500668 A JP 2009500668A JP 2009500668 A JP2009500668 A JP 2009500668A JP 2009530316 A5 JP2009530316 A5 JP 2009530316A5
Authority
JP
Japan
Prior art keywords
agent
composition
contraceptive composition
contraceptive
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500668A
Other languages
English (en)
Japanese (ja)
Other versions
JP5322918B2 (ja
JP2009530316A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2007/000352 external-priority patent/WO2007106944A1/en
Publication of JP2009530316A publication Critical patent/JP2009530316A/ja
Publication of JP2009530316A5 publication Critical patent/JP2009530316A5/ja
Application granted granted Critical
Publication of JP5322918B2 publication Critical patent/JP5322918B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009500668A 2006-03-22 2007-03-21 避妊用組成物 Active JP5322918B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2006901474 2006-03-22
AU2006901474A AU2006901474A0 (en) 2006-03-22 Composition
PCT/AU2007/000352 WO2007106944A1 (en) 2006-03-22 2007-03-21 Contraceptive composition

Publications (3)

Publication Number Publication Date
JP2009530316A JP2009530316A (ja) 2009-08-27
JP2009530316A5 true JP2009530316A5 (cg-RX-API-DMAC7.html) 2010-04-08
JP5322918B2 JP5322918B2 (ja) 2013-10-23

Family

ID=38521950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500668A Active JP5322918B2 (ja) 2006-03-22 2007-03-21 避妊用組成物

Country Status (8)

Country Link
US (1) US8193248B2 (cg-RX-API-DMAC7.html)
EP (1) EP1996209B1 (cg-RX-API-DMAC7.html)
JP (1) JP5322918B2 (cg-RX-API-DMAC7.html)
CN (1) CN101405010B (cg-RX-API-DMAC7.html)
AU (1) AU2007229268B2 (cg-RX-API-DMAC7.html)
CA (1) CA2640978C (cg-RX-API-DMAC7.html)
ES (1) ES2558875T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007106944A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103123A1 (en) * 2008-02-22 2009-08-27 Starpharma Pty Limited Dendrimeric enzyme inhibitors
GB2475013A (en) * 2008-09-16 2011-05-04 Playtex Products Llc Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administrating same
US20110086044A1 (en) * 2009-09-29 2011-04-14 University Of Southern California Compositions and Methods to Inhibit HPV Infection
US20110077263A1 (en) * 2009-09-29 2011-03-31 University Of Southern California Methods and Compositions of Toll-Like Receptor (TLR) Agonists
HUE047170T2 (hu) * 2011-05-16 2020-04-28 Starpharma Pty Ltd Bakteriális vaginózis kezelési vagy megelõzési módszere
MX2015005328A (es) 2012-10-26 2015-09-25 Nlife Therapeutics S L Composiciones y metodos para la administracion selectiva de moleculas de oligonucleotidos a tipos de celulas.
US20150320675A1 (en) * 2013-01-18 2015-11-12 University Of Utah Research Foundation Modified Release Osmotic Pump for PH-Responsive Drug Delivery
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
BR112017000285A2 (pt) * 2014-07-07 2017-10-31 Prophylaxis LLC métodos de tratamento da profilaxia viral e kits de profilaxia de pré-exposição
GB201617063D0 (en) * 2016-10-07 2016-11-23 Cambridge Design Research Llp Condoms

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
GB9407812D0 (en) 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
AUPO104496A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US6191120B1 (en) * 1998-03-25 2001-02-20 Wayne Hughes Institute Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions
US6192887B1 (en) * 1998-05-19 2001-02-27 The Pennsylvania State University Broad spectrum microbicidal and spermicidal compositions and methods having activity against sexually transmitted agents including papillomaviruses
AUPP584398A0 (en) 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances
AUPP584298A0 (en) 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
CA2402520A1 (en) * 2000-03-13 2001-09-20 Kenneth Beckman Biocidal methods and compositions
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
CA2346188A1 (en) * 2001-05-02 2002-11-02 Bradley Benson Male sexual aid device
IL163812A0 (en) 2002-03-05 2005-12-18 Univ Ramot Immunizing composition and method for inducing an immune response against the -secretase cleavage site of amyloid precursor protein
EP1487432B1 (en) * 2002-03-26 2013-03-06 Eastern Virginia Medical School Suramin and derivatives thereof as topical microbicide and contraceptive

Similar Documents

Publication Publication Date Title
CA2632626C (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
JP2009531403A5 (cg-RX-API-DMAC7.html)
JP2004509061A5 (cg-RX-API-DMAC7.html)
CN101405010B (zh) 避孕组合物
JP2007197470A5 (cg-RX-API-DMAC7.html)
JP2017537158A5 (cg-RX-API-DMAC7.html)
JP2003526673A5 (cg-RX-API-DMAC7.html)
JP2007509902A5 (cg-RX-API-DMAC7.html)
WO2010134851A1 (ru) Средство для профилактики и лечения высокопатогенных инфекционных заболеваний
CA2441357A1 (en) Agent for the prevention and treatment of sexually transmitted diseases-i
US11439610B2 (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides
JP2010536063A5 (cg-RX-API-DMAC7.html)
JP2021510147A (ja) ストーマ周囲領域用スキンケア組成物
JP2009527505A5 (cg-RX-API-DMAC7.html)
JP2004530737A5 (cg-RX-API-DMAC7.html)
JP2005514358A5 (cg-RX-API-DMAC7.html)
RU2008119505A (ru) Система доставки микробицидных дендримерных композиций
Lau et al. Detection of human papillomavirus types in balanitis xerotica obliterans and other penile conditions.
CA2441292A1 (en) Equine herpesvirus vaccine
JPH11199647A5 (cg-RX-API-DMAC7.html)
JP2004509839A5 (cg-RX-API-DMAC7.html)
TW200524622A (en) Activated carbon for preventing pregnancy and sexually transmitted disease
JP2021513569A5 (cg-RX-API-DMAC7.html)
US20090247639A1 (en) Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv
CN116322666A (zh) 包含透明质酸和角叉菜胶的局部抗病毒组合物